China bans clinical research in germline genome editing as ‘irresponsible’

China bans clinical research in germline genome editing as ‘irresponsible’

The guideline marks the latest effort from China to tighten ethics reviews and regulations after bioscientist He Jiankui shocked the world in 2018 with the announcement that he had created twin gene-edited babies to make them less vulnerable to HIV/Aids. “Only when benefits, risks and alternative options are fully understood and weighed, when issues of … Read more